A Long-Acting Phenothiazine as a Possible Agent to Control Deviant Sexual Behavior
Abstract
Various techniques have been tried in an endeavor to control deviant sexual drive. This paper presents the results obtained using a long-acting phenothiazine given intramuscularly and working on a depot basis, the theoretical advantages being a lesser incidence of gynecomastia than with estrogens, and the necessity for less patient cooperation than with oral medication. The results in both sexually normal and deviant groups suggest that the drug is of value in reducing sexual drive and performance, with no undue side effects observed provided antiparkinsonian drugs are given.
Access content
To read the fulltext, please use one of the options below to sign in or purchase access.- Personal login
- Institutional Login
- Sign in via OpenAthens
- Register for access
-
Please login/register if you wish to pair your device and check access availability.
Not a subscriber?
PsychiatryOnline subscription options offer access to the DSM-5 library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.
Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).
